6-(1H-benzoimidazol-2-yl)-5-chloro-pyridin-2-ylamine | 886435-78-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 英文名称: 6-(1H-benzoimidazol-2-yl)-5-chloro-pyridin-2-ylamine
• 英文别名: 6-(1H-benzimidazol-2-yl)-5-chloropyridin-2-amine
• CAS: 886435-78-5
• 化学式: C₁₂H₉ClN₄
• 分子量: 244.683
• InChiKey: OVJSIQYSJJIGLR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  17
• 可旋转键数：
  1
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  67.6
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  2-(3,6-dichloro-pyridin-2-yl)-1H-benzoimidazole 在 氨 作用下， 以 乙醇 为溶剂， 140.0 ℃ 、1.38 MPa 条件下， 反应 33.33h， 以21%的产率得到6-(1H-benzoimidazol-2-yl)-5-chloro-pyridin-2-ylamine
  参考文献：
  名称：

  WO2006/50506

  摘要：

  公开号：

文献信息

• Mediators of Hedgehog Signaling Pathways, Compositions and Uses Related Thereto
  申请人：Guicherit Olivin M.

  公开号：US20090012082A1

  公开（公告）日：2009-01-08

  The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function, ptc loss-of-function or smoothened gain-of-function comprising contacting the cell with a hedgehog antagonist, such as a small molecule, in a sufficient amount to aberrant growth state, e.g., to agonize a normal ptc pathway or antagonize smoothened or hedgehog activity.

  本发明提供了用于抑制由于hedgehog增强功能、ptc失去功能或smoothened增强功能导致的异常生长状态的方法和试剂，包括将细胞与hedgehog拮抗剂（如小分子）接触，以足够的剂量抑制异常生长状态，例如，激活正常的ptc通路或拮抗smoothened或hedgehog活性。
• Mediators of hedgehog signaling pathways, compositions and uses related thereto
  申请人：Curis, Inc.

  公开号：US08168653B2

  公开（公告）日：2012-05-01

  The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function, ptc loss-of-function or smoothened gain-of-function comprising contacting the cell with a hedgehog antagonist of formula (I) in a sufficient amount to aberrant growth state, e.g., to agonize a normal ptc pathway or antagonize smoothened or hedgehog activity.

  本发明提供了抑制因hedgehog基因增强功能、ptc基因失活功能或smoothened基因增强功能导致的异常生长状态的方法和试剂，包括将细胞与式（I）的hedgehog拮抗剂接触，以足够的剂量抑制异常生长状态，例如，激活正常的ptc通路或拮抗smoothened或hedgehog活性。
• MEDIATORS OF HEDGEHOG SIGNALING PATHWAYS, COMPOSITIONS AND USES RELATED HERETO
  申请人：GUICHERIT Oivin M.

  公开号：US20120283258A1

  公开（公告）日：2012-11-08

  The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function, ptc loss-of-function or smoothened gain-of-function comprising contacting the cell with a hedgehog antagonist of formula (I) in a sufficient amount to aberrant growth state, e.g., to agonize a normal ptc pathway or antagonize smoothened or hedgehog activity.

  本发明提供了一种方法和试剂，用于抑制由于刺猬增益功能、ptc失活或smoothened增益功能导致的异常生长状态，包括将细胞与式(I)的刺猬拮抗剂接触，以足够的量抑制异常生长状态，例如激活正常的ptc途径或拮抗smoothened或刺猬活性。
• Mediators of hedgehog signaling pathways, compositions and uses related hereto
  申请人：Guicherit Oivin M.

  公开号：US08815895B2

  公开（公告）日：2014-08-26

  The present invention makes available methods and reagents for inhibiting aberrant growth states resulting from hedgehog gain-of-function, ptc loss-of-function or smoothened gain-of-function comprising contacting the cell with a hedgehog antagonist of formula (I) in a sufficient amount to aberrant growth state, e.g., to agonize a normal ptc pathway or antagonize smoothened or hedgehog activity.

  本发明提供了一种抑制由于刺猬增强功能、ptc失去功能或smoothened增强功能导致的异常生长状态的方法和试剂，包括将细胞与公式（I）的刺猬拮抗剂接触，以足够的量抑制异常生长状态，例如激活正常ptc通路或拮抗smoothened或刺猬活性。
• MEDIATORS OF HEDGEHOG SIGNALING PATHWAYS, COMPOSITIONS AND USES RELATED THERETO
  申请人：Curis, Inc.

  公开号：EP1807074A1

  公开（公告）日：2007-07-18